Chronic platelet activation and acute coronary syndromes in 13 middle- aged patients

Clinical and Applied Thrombosis/Hemostasis

Volumn 3, Issue 1, 1997, Pages 46-53

  Ozner, Michael D ^a   Ahn, Yeon S ^a   Horstman, Lawrence L ^a   Jy, Wenche ^a   Kolodny, Luciano ^a   Myerberg, Robert J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndromes; Chronic platelet activation; Immune thrombocytopenia; Middle age; Platelet microparticles; Platelet associated IgM

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; ANGIOGRAPHY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CORONARY RISK; DISEASE ASSOCIATION; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

EID: 0031421509     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969700300107     Document Type: Article

References (37)

1. Weiss HJ. Ischemic heart disease: possible role of platelets. In: Weiss HJ, ed. Platelets, Pathophysiology and antiplatelet drug therapy. New York: Alan R. Liss, 1982:180.
2. Badimon L, Badimon JJ, Fuster V. Pathogenesis of thrombosis. In: Fuster V, Verstrate M, eds. Thrombosis in cardiovascular disorders. Philadelphia: W. B. Saunders, 1992:17.
3. Fitzgerald DJ, Roy L, Catella F, et al. Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983.
4. Davies MY, Thomas AD, Knapman PA, et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986;73: 418.
5. Sobel M, Salzman E, Davies GC, et al. Circulating platelet products in unstable angina pectoris. Circulation 1981;63: 300.
6. Haft JI, Kranz PD, Albert FJ, et al. Intravascular platelet aggregation in the heart induced by norepinephrine. Circulation 1972;46:698.
7. Haft JI, Gershengorn K, Kranz PD, et al. Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation. Am J Cardiol 1972;30:838.
8. Folts JD, Crowell EB Jr, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976;54:365.
9. Falk E. Unstable angina with fatal outcome: dynamic coronary stenosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699.
10. Salky N, Dugdale MD. Platelet abnormalities in ischemic heart disease. Am J Cardiol 1973;32:612.
11. Bode AP, Sandberg H, Dembrose FA, et al. Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation. Thromb Res 1985;119:334.
12. Sims PJ, Faioni EM, Weidmer T, et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988;263:18205.
13. Sims PJ, Wiedmen T, Esmon CT, et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott's syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989;264:17049.
14. Jy W, Horstman LL, Arce M, et al. Clinical significance of platelet microparticles in autoimmune thrombocytopenia. J Lab Clin Med 1992;119:334.
15. Horstman LL, Jy W, Schultz, et al. Complement mediated fragmentation and lysis of opsonized platelets: gender differences in sensitivity. J Lab Clin Med 1994;123:515.
16. Lee Y, Jy W, Horstman LL, et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993;72:295.
17. Ahn YS, Ozner MD, Janania J, et al. Platelet activation and coronary ischemic syndromes. Br J Hematol 1992;24th Congr ISH Abstr No 327:83.
18. Ozner MD, Ahn YS, Jy W, Horstman L, et al. Acute coronary syndromes and elevated platelet microparticles in immune thrombocytopenias. Blood 1992;82:1256(a).
19. Howard MA, Coghlan M, David R, et al. Coagulation activities of plasma microparticles. Thromb Res 1988;50:145.
20. Jy W, Horstman L, Wang F, et al. Platelet factor 3 in plasma fractions: its relation to microparticle size and thrombosis. Thromb Res 1995;80:471.
21. Ahn YS, Rocha R, Mylvaganam R, et al. Long-Term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women. Ann Intern Med 1989;111:73.
22. Jy W, Ahn YS, Harrington WJ, et al. Abnormal calcium handling by platelets in thrombotic disorders. Circ Res 1987; 60:346.
23. Shanbaky N, Ahn YS, Jy W, et al. Abnormal aggregation and calcium handling of platelets in thrombosis. Haemost Thromb 1987;57:1.
24. Ritchie JL, Harker LA. Platelet and fibrinogen survival in coronary atherosclerosis. Am J Cardial 1977;39:595.
25. Murphy EA, Mustard JF. Coagulation tests and platelet economy in atherosclerotic and control subjects. Circulation 1962;25:114.
26. Karpatkin S, Siskind GW. In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood 1969;33:795.
27. Hirschman RJ, Shulman NR. The use of platelet serotonin release as a sensitive method for detecting anti-platelet antibodies and a plasma anti-platelet factor in patients with idiopathic thrombocytopenic purpura. Br J Haematol 1973:24:793.
28. Boucheix C, Carroll RC, Worthington RE, et al. Platelet response to antiplatelet antibodies. Semin Thromb Hemost 1995;21:1.
29. Pfueller SL, David R, Firkin BG, et al. Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombocytopenia. Br J Haematol 1990;74:336.
30. Rubenstein E, Urso I, Boucheix C, et al. Platelet activation by cross linking HLA class I molecules and Fc receptor. Blood 1992;79:2901.
31. Lin YL, Wang CT. Activation of human platelets by the rabbit cardiolipin antibodies. Blood 1992;80:3135.
32. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1.
33. Spiera H, Rothenberg RR. Myocardial infarction in four young patients with SLE. J Rheum 1983;10:464.
34. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthr Rheum 1982;25:612.
35. Petri M, Spence D, Bone LR, et al. Coronary disease risk factors in the John Hopkins lupus cohort, prevalence, recognition by patients and preventive practice. Medicine (Baltimore) 1992;71:291.
36. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk and intervention assessment. Ann Intern Med 1993;119:1187.
37. Guido G, Soffiantino F, Zucchella M, et al. Platelet activation by emotional stress in patients with coronary artery disease. Circulation 1991;83:128.